Skip to content

BPCO Ointment 1

by Brookfield Pharmaceuticals, LLC

BPCO Ointment 1 is a skin semi-occlusive dressing (FDA Class I; FDA product code NAD, Dressing, Wound, Occlusive) made by Brookfield Pharmaceuticals, LLC, listed in FDA GUDID since 15 Nov 2023 (UDI-DI 00371351014603), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00371351014603 UDI-DI Date15 Nov 2023ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
Class I (general controls), 510(k) exempt medical device with a product code of NAD. Per the Code of Federal Regulations, it is regulated under 21 CFR 878.4020 as an occlusive wound dressing.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
BPCO Ointment
Generic name
Skin semi-occlusive dressing, non-antimicrobial
Model / reference
1
Primary DI / UDI-DI
00371351014603
FDA product code
NAD
GMDN term
Skin semi-occlusive dressing, non-antimicrobial
Device class
Class I
Regulation number
878.4020
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code NAD (Dressing, Wound, Occlusive).

Properties

  • Prescription use
  • Premarket exempt
Other properties (13, all answered No)